Albireo Pharma Inc.
13F holders, Q1 2025 (March 31)2holders −1
1new positions
2sold out
$0.00avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Albireo Pharma Inc. in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were Brooklyn Investment Group ($0) and ORG Partners LLC ($0).
- Company
- Albireo Pharma Inc.
- CUSIP
- 013CVR022
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 2 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 8 shares bought and 170 shares sold, net −162 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Brooklyn Investment Group | 0.00% | No change | 10 | $0 |
| ORG Partners LLC | 0.00% | New | 8 | $0 |
"% of holder's portfolio" is ALBIREO PHARMA INC's weight in each manager's 13F, not the share of Albireo Pharma Inc. the manager owns.